Biocon to merge biologics unit; to acquire stake held by Serum, Mylan

Biocon will acquire the remaining stake in Biocon Biologics Limited through a share swap, valuing Biocon Biologics at $5.5 billion

Dec 7, 2025 - 06:30
 0
Biocon to merge biologics unit; to acquire stake held by Serum, Mylan
Biocon will acquire the remaining stake in Biocon Biologics Limited through a share swap, valuing Biocon Biologics at $5.5 billion

What's Your Reaction?

like

dislike

love

funny

angry

sad

wow